Download Technology Capabilities
Public biomarker data can be analyzed and combined with enterprise data to gain new insights. This is enabled by our patent-pending technologies that normalize and understand the language of life science.
AI-enabled algorithms generate unbiased sets of hypotheses for potential biomarkers or combinations testing all possible scenarios.
Extensive biological multigraph-based scientific validation over public knowledge is deployed to ensure high biomarker prediction accuracy while removing false positives.
Continuous intuitive interface transparently visualizes interpretation of AI output with relevant network and provenances from public literature.
Life sciences data, coupled with Innoplexus’s AI and data analytics solutions, can help researchers accurately pinpoint novel biomarkers. Our proprietary technology provides deep-dive insights to predict biomarker response in a disease model or along pathways.
Increase the likelihood of regulatory approval by predicting biomarker response.
Stratify patient groups with relevant biomarkers for maximum returns.
Assess biomarkers to find the right ones for your clinical trials and improve the probability of success.
Chemicals & Drugs
Theses & Dissertations